课题基金 / 基金详情

项目摘要

项目成果

Andrew T Gewirtz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Viral infections cause and/or promote many of humanity's most intractable health problems. Most viral infections can neither be prevented nor cured thus leaving a great need for novel strategies to combat these infectious agents. This proposal seeks to help fill this chasm by investigating our startling recent discovery of the existence of a novel potent innate immune antiviral mechanism. Specifically, using murine rotavirus (RV) infection as a model of an acute diarrhea---inducing infection in young mice and a chronic infection in immune---deficient mice, we recently made the unexpected observation that systemic administration of bacterial flagellin could prevent or eliminate ongoing rotavirus infection. Flagellin's antiviral action was independent of adaptive immunity and interferon (type and II) while requiring hemopoietic cell expression of both known flagellin receptors, toll---like receptor 5 (TLR5) and Nod---like receptor C4 (NLRC4). Flagellin's blockade of rotavirus infection may be utilizing pathways that normally mediate bacterial---viral competition/crosstalk or prove to be a purely engineered approach that does not mimic a naturally occurring in vivo process. Regardless, that exogenously administered flagellin results in rapid cure of chronic viral infections that would not otherwise be resolved by immune compromised hosts suggests the possibility that this mechanism, if understood and harnessed, might provide new weapons against some of the numerous viruses that continue to plague humanity. Thus, while development of new modalities to treat rotavirus infection is one potential outcome of this project, the primary overall goal of this proposal is to define the mechanism underlying flagellin' antiviral action so it can be harnessed to develop novel strategies to treat a variety of viral infections. We will employ a series of inter---related genetic, immunological and biochemical approaches to define the cell type(s), soluble mediator(s) that cure and prevent RV infection and decipher their mode of action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intestinal microbiota-mediated rotavirus vaccine failure
  • 批准号:
    10586698
  • 项目类别:
  • 资助金额:
    $77.25万
  • 财政年份:
    2022
  • 负责人:
    Andrew T Gewirtz
  • 依托单位:
Intestinal microbiota-mediated rotavirus vaccine failure
  • 批准号:
    10707184
  • 项目类别:
  • 资助金额:
    $78.37万
  • 财政年份:
    2022
  • 负责人:
    Andrew T Gewirtz
  • 依托单位:
Intestinal M Cells and Secretory IgA Response to Defined Gut Microbiota
  • 批准号:
    8684523
  • 项目类别:
  • 资助金额:
    $24.39万
  • 财政年份:
    2014
  • 负责人:
    Andrew T Gewirtz
  • 依托单位:
Intestinal M Cells and Secretory IgA Response to Defined Gut Microbiota
  • 批准号:
    8793099
  • 项目类别:
  • 资助金额:
    $19.09万
  • 财政年份:
    2014
  • 负责人:
    Andrew T Gewirtz
  • 依托单位:
海外基金